Award details

Marek's disease virus pathogenesis and disease resistance

ReferenceBBS/E/I/00001111
Principal Investigator / Supervisor Professor Venugopal Nair
Co-Investigators /
Co-Supervisors
Institution The Pirbright Institute
DepartmentThe Pirbright Institute Department
Funding typeResearch
Value (£) 308,156
StatusCompleted
TypeInstitute Project
Start date 15/06/2005
End date 13/01/2010
Duration55 months

Abstract

Marek's disease (MD) is a highly contagious disease caused by an oncogenic alphaherpesvirus. Control of MD is currently achieved by vaccination with live attenuated vaccines. However, the emergence of more virulent strains of Marek's disease virus (MDV) has indicated that alternative strategies will be required to control this disease in the future. A key objective of this proposal is to identify genes associated with the pathogenesis and latency of MDV infection and to exploit this knowledge to develop disease resistant chickens. The strategy will involve analysing gene function using siRNA technology and generation of chickens expressing siRNA transgenically in order to define gene function during MDV infection. The investigation will focus on known transforming/latency genes such as Meq, MSRs (Marek's disease small RNAs) and ICP4 as well as characterising genes of unknown function. Meq will be used as a 'proof of principle' for siRNA disruption of viral oncogenesis in transgenic chickens.

Summary

unavailable
Committee Closed Committee - Animal Sciences (AS)
Research TopicsAnimal Health, Immunology, Microbiology
Research PriorityX – Research Priority information not available
Research Initiative X - not in an Initiative
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file